Home › Disturbo depressivo maggiore › Illinois › Chicago
Studi clinici su Disturbo depressivo maggiore a Chicago, IL
17 studi su Disturbo depressivo maggiore cercano partecipanti presso sedi a Chicago e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
In reclutamentoFase 3
- Charter Research - Chicago, Chicago
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
In reclutamentoFase 3
- Chicago Research Center, Chicago
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
In reclutamentoFase 3
- Northwestern University, Chicago
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 2
- Chicago Research Center, Chicago
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
In reclutamentoFase 3
- Rush University, Chicago
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
In reclutamentoFase 3
- Vanda Investigational Site, Chicago
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
In reclutamentoFase 2
- Draig Clinical Site, Chicago
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
In reclutamento
- Rush University Medical Center, Chicago
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
In reclutamentoFase 3
- Uptown Research Institute, Chicago
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
In reclutamentoFase 2
- EmVenio Research, Chicago
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
In reclutamentoFase 3
- Clinical Research Site, Chicago
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
In reclutamentoFase 2
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
In reclutamento
- University of Illinois at Chicago, Chicago
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
In reclutamentoFase 2
- Pillar Clinical Research LLC, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
In reclutamentoStudio osservazionale
- University of Chicago Medical Center, Chicago
Study of ALTO-300 in MDD
In reclutamentoFase 2
- Site 310, Chicago
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
In reclutamentoFase 4
- Clinical Research Site, Chicago
Studi su Disturbo depressivo maggiore in altre città
- New York City, NY37 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Tampa, FL17 studi
- Houston, TX16 studi
- San Diego, CA16 studi
- Little Rock, AR14 studi
- Orange, CA13 studi
- Austin, TX13 studi
Altri studi a Chicago
- Cancro del polmone non a piccole cellule61 studi
- Cancro al seno58 studi
- Cancro (tutti i tipi)51 studi
- Cancro metastatico45 studi
- Cancro alla prostata45 studi
- Obesità41 studi
- Cancro ai polmoni41 studi
- Cancro ovarico36 studi
- Ictus34 studi
- Cancro colorettale33 studi
- Insufficienza cardiaca31 studi
- Sovrappeso28 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.